Related Experiment Video
Updated: Jun 12, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
New frontiers of HCV therapy in HIV/HCV co-infection
1Department of Medicine, University of Pennsylvania, 8th Floor, Philadelphia VAMC, Philadelphia, PA 19104, USA. Valerianna.Amorosa@uphs.upenn.edu
Abstract:
Hepatitis C virus (HCV) leads to disproportionate morbidity and mortality in the HIV-positive population. A new era of anti-HCV therapeutics is emerging, with many direct antiviral agents and immunomodulating drugs in clinical development. This review discusses HCV treatments in development, with special attention to four agents being studied actively among HIV/HCV-co-infected persons.
Related Concept Videos
Retrovirus Life Cycles
Viral Hepatitis I: Introduction
Antiviral Nucleoside Inhibitors
Hepatitis
Inhibitors of Viral Protein Synthesis
Retroviruses

